Lipid News

Lipid regulation of mitochondria

Yoshihiro Adachi Miho Iijima Hiromi Sesaki
By Yoshihiro Adachi, Miho Iijima and Hiromi Sesaki
May 1, 2019

Mitochondria are dynamic organelles that grow, divide and fuse in most of the human body’s cells; these dynamic membrane processes are critical for mitochondrial health.

Our laboratory studies mitochondrial division and fusion, focusing on three mechanochemical dynamin-related GTPases: Drp1, mitofusin and Opa1. Drp1 is a soluble GTPase that splits the mitochondrial membrane. Mitofusin and Opa1 are integral membrane GTPases that work together to fuse the mitochondrial membranes. Mutations in each of these enzymes lead to human diseases that mainly affect central and peripheral nervous systems.

Mitochondrial division and fusion need to be balanced to maintain functional mitochondrial size, structure and distribution within cells. This dynamic balance is controlled by several layers of mechanisms, including gene expression, post-translational modifications and protein degradation of these GTPases and their binding partners. In addition, mitochondrial phospholipids play important roles in regulation of mitochondrial dynamics.

CardiolipinCardiolipin, or CL, in the mitochondrial outer membrane promotes oligomerization of Drp1 to drive mitochondrial division; CL in the inner membrane mediates fusion through heterotypic interactions with Opa1. Hiromi Sesaki et al.Drp1 interacts with two phospholipids, cardiolipin, or CL, and phosphatidic acid, or PA, in the mitochondrial outer membrane, or OM. CL is synthesized in the mitochondrial inner membrane, or IM, and a fraction of CL is transported to the OM. Drp1 is recruited to the mitochondria through its receptor proteins on the surface of mitochondria; binding to CL stimulates Drp1 to assemble into high-order oligomers that function as a division machinery. The machinery is regulated further by PA. Binding to PA restrains the assembled machinery from initiating the constriction of the mitochondrial membranes, likely creating a priming step for mitochondrial division. Binding sites for CL and PA are different in Drp1; therefore, these phospholipids may create different degrees of the regulation through a combination of single or concurrent binding to Drp1.

The production of CL and PA is a dynamic process in the OM. As described above, CL is transported to the OM from the IM. This transport may be regulated through dynamic interactions at the intramitochondrial OM-IM contact sites. In the OM, there is a phospholipase D, MitoPLD, which converts CL to PA. Since MitoPLD directly binds Drp1, conversion of stimulatory CL to inhibitory PA may happen locally in the vicinity of the division machinery. PA also is produced in the endoplasmic reticulum, or ER, and imported into the OM through ER-mitochondrial contact sites. Drp1 often divides mitochondria at these sites. Mitochondrial PA levels also may be regulated by this interorganellar interaction.

PA changes the mitochondrial membrane’s biophysical properties and facilitates mitofusion-mediated membrane fusion. Opa1, similar to Drp1, binds CL, and this interaction drives membrane fusion. Therefore, lipid transport and synthesis coupled to intramitochondrial contact site dynamics and interorganellar interactions play key roles in controlling mitochondrial dynamics.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Yoshihiro Adachi
Yoshihiro Adachi

Yoshihiro Adachi is a postdoctoral fellow in Hiromi Sesaki’s lab in the department of cell biology at the Johns Hopkins University School of Medicine.

Miho Iijima
Miho Iijima

Miho Iijima is an associate professor in the department of cell biology at the Johns Hopkins University School of Medicine.

Hiromi Sesaki
Hiromi Sesaki

Hiromi Sesaki is a professor in the department of cell biology at the Johns Hopkins University School of Medicine.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

What’s in a diagnosis?
Essay

What’s in a diagnosis?

Sept. 4, 2025

When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Annual Meeting

Peer through a window to the future of science

Sept. 3, 2025

Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
Journal News

Glow-based assay sheds light on disease-causing mutations

Sept. 2, 2025

University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.